Logo image of ACB.CA

AURORA CANNABIS INC (ACB.CA) Stock Price, Quote, News and Overview

TSX:ACB - Toronto Stock Exchange - CA05156X8504 - Common Stock - Currency: CAD

7.43  -0.2 (-2.62%)

ACB.CA Quote, Performance and Key Statistics

AURORA CANNABIS INC

TSX:ACB (8/14/2025, 7:00:00 PM)

7.43

-0.2 (-2.62%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High9.9
52 Week Low4.95
Market Cap417.94M
Shares56.25M
Float56.22M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE12.68
Earnings (Next)11-04 2025-11-04/bmo
IPO09-26 2007-09-26


ACB.CA short term performance overview.The bars show the price performance of ACB.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

ACB.CA long term performance overview.The bars show the price performance of ACB.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of ACB.CA is 7.43 CAD. In the past month the price increased by 21.21%. In the past year, price decreased by -22.2%.

AURORA CANNABIS INC / ACB Daily stock chart

ACB.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.99 3.84B
TLRY.CA TILRAY BRANDS INC N/A 1.79B
CRON.CA CRONOS GROUP INC 49.57 1.34B
DHT-UN.CA DRI HEALTHCARE TRUST 6.69 790.88M
GUD.CA KNIGHT THERAPEUTICS INC 56.82 622.81M
DHT-U.CA DRI HEALTHCARE TRUST 4.89 577.75M
WEED.CA CANOPY GROWTH CORP N/A 476.70M
TSND.CA TERRASCEND CORP N/A 425.05M
CPH.CA CIPHER PHARMACEUTICALS INC 28.8 368.93M
OGI.CA ORGANIGRAM GLOBAL INC N/A 286.50M
HITI.CA HIGH TIDE INC N/A 285.01M
XLY.CA AUXLY CANNABIS GROUP INC 16.5 220.32M

About ACB.CA

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,073 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T9E 0V6 CA

CEO: Miguel Martin

Employees: 1073

ACB Company Website

ACB Investor Relations

Phone: 16043625207

AURORA CANNABIS INC / ACB.CA FAQ

What is the stock price of AURORA CANNABIS INC today?

The current stock price of ACB.CA is 7.43 CAD. The price decreased by -2.62% in the last trading session.


What is the ticker symbol for AURORA CANNABIS INC stock?

The exchange symbol of AURORA CANNABIS INC is ACB and it is listed on the Toronto Stock Exchange exchange.


On which exchange is ACB.CA stock listed?

ACB.CA stock is listed on the Toronto Stock Exchange exchange.


What is the price forecast or stock price prediction for AURORA CANNABIS INC stock?

9 analysts have analysed ACB.CA and the average price target is 8.59 CAD. This implies a price increase of 15.66% is expected in the next year compared to the current price of 7.43. Check the AURORA CANNABIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AURORA CANNABIS INC worth?

AURORA CANNABIS INC (ACB.CA) has a market capitalization of 417.94M CAD. This makes ACB.CA a Small Cap stock.


How many employees does AURORA CANNABIS INC have?

AURORA CANNABIS INC (ACB.CA) currently has 1073 employees.


What are the support and resistance levels for AURORA CANNABIS INC (ACB.CA) stock?

AURORA CANNABIS INC (ACB.CA) has a support level at 6.6 and a resistance level at 7.47. Check the full technical report for a detailed analysis of ACB.CA support and resistance levels.


Is AURORA CANNABIS INC (ACB.CA) expected to grow?

The Revenue of AURORA CANNABIS INC (ACB.CA) is expected to grow by 10.41% in the next year. Check the estimates tab for more information on the ACB.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AURORA CANNABIS INC (ACB.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AURORA CANNABIS INC (ACB.CA) stock pay dividends?

ACB.CA does not pay a dividend.


When does AURORA CANNABIS INC (ACB.CA) report earnings?

AURORA CANNABIS INC (ACB.CA) will report earnings on 2025-11-04, before the market open.


What is the Price/Earnings (PE) ratio of AURORA CANNABIS INC (ACB.CA)?

AURORA CANNABIS INC (ACB.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).


ACB.CA Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ACB.CA. When comparing the yearly performance of all stocks, ACB.CA is a bad performer in the overall market: 84.94% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ACB.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ACB.CA. While ACB.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB.CA Financial Highlights

Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 46.18% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.66%
ROA 0.27%
ROE 0.4%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%-300.92%
Sales Q2Q%24.38%
EPS 1Y (TTM)46.18%
Revenue 1Y (TTM)27.32%

ACB.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 73% to ACB.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 578.72% and a revenue growth 10.41% for ACB.CA


Ownership
Inst Owners19.7%
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
Analysts
Analysts73.33
Price Target8.59 (15.61%)
EPS Next Y578.72%
Revenue Next Year10.41%